Difference between revisions of "Flexible tissues"
Jump to navigation
Jump to search
(Created page with "In flexible (Type F) tissues all cells are assumed to have the potential for proliferation and are also engaged in tissue-specific functions. The pronounced dose-latency relat...") |
|||
| Line 1: | Line 1: | ||
In flexible (Type F) tissues all cells are assumed to have the potential for proliferation and are also engaged in tissue-specific functions. The pronounced dose-latency relationship results from the dose-dependent loss of proliferating functional cells through their mitotic death, together with the feedback-mediated stimulation of compensatory proliferation, leading to an even enhanced cell loss by doomed divisions. | In flexible (Type F) tissues all cells are assumed to have the potential for proliferation and are also engaged in tissue-specific functions. The pronounced dose-latency relationship results from the dose-dependent loss of proliferating functional cells through their mitotic death, together with the feedback-mediated stimulation of compensatory proliferation, leading to an even enhanced cell loss by doomed divisions. | ||
| + | ''ICRP Glossary entry - June 2019'' | ||
| − | ''[[ICRP Glossary]] | + | |
| + | '''Return to [[ICRP Glossary|Glossary]]''' | ||
Revision as of 20:05, 12 September 2019
In flexible (Type F) tissues all cells are assumed to have the potential for proliferation and are also engaged in tissue-specific functions. The pronounced dose-latency relationship results from the dose-dependent loss of proliferating functional cells through their mitotic death, together with the feedback-mediated stimulation of compensatory proliferation, leading to an even enhanced cell loss by doomed divisions.
ICRP Glossary entry - June 2019
Return to Glossary
